Recombinant Human SSSCA1 protein (denatured) (His tag N-Terminus)
Recombinant Human SSSCA1 protein (denatured) (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human SSSCA1 protein (denatured) (His tag N-Terminus) is a Human Full Length protein, in the 1 to 199 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE.
別名を表示する
SSSCA1, ZNRD2, Protein ZNRD2, Autoantigen p27, Protein zinc ribbon domain type 2, Sjoegren syndrome/scleroderma autoantigen 1, Zinc ribbon domain-containing protein 2
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human SSSCA1 protein (denatured) (His tag N-Terminus) (AB174559)
15% SDS-PAGE analysis of ab174559 (3 μg)
Reactivity data
配列情報
出荷温度及び保存条件
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein acts as a critical player in the regulation of mitosis. SSSCA1 forms part of a larger multiprotein complex essential for the proper attachment of chromosomes to the mitotic spindle. By ensuring that the chromosomes align correctly SSSCA1 facilitates accurate segregation during cell division. It works closely with other components of the complex to maintain genomic stability.
Pathways
The protein influences critical cell division processes. SSSCA1 integrates into the spindle assembly checkpoint pathway ensuring the proper timing of mitosis. Within this pathway it often interacts with proteins such as BubR1 and Mad2 which are responsible for halting cell cycle progression until chromosomes are correctly attached to the spindle fibers. Its role in checkpoint pathways highlights its importance in maintaining orderly mitotic progression.
製品の性状
製品の状態
Liquid
一般的な情報
機能
Might play a role in mitosis. Antigenic molecule. Could be a centromere-associated protein. May induce anti-centromere antibodies.
ターゲットの情報
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com